EP1079764A4 - Traitement des troubles de la sexualite chez certains groupes de patients - Google Patents

Traitement des troubles de la sexualite chez certains groupes de patients

Info

Publication number
EP1079764A4
EP1079764A4 EP99920266A EP99920266A EP1079764A4 EP 1079764 A4 EP1079764 A4 EP 1079764A4 EP 99920266 A EP99920266 A EP 99920266A EP 99920266 A EP99920266 A EP 99920266A EP 1079764 A4 EP1079764 A4 EP 1079764A4
Authority
EP
European Patent Office
Prior art keywords
treatment
sexual dysfunction
patient groups
certain patient
certain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99920266A
Other languages
German (de)
English (en)
Other versions
EP1079764A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RT Alamo Ventures I LLC
Original Assignee
RT ALAMO VENTURES Inc
RT ALAMO VENTURES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/071,457 external-priority patent/US6110489A/en
Priority claimed from US09/166,703 external-priority patent/US6194433B1/en
Priority claimed from US09/175,395 external-priority patent/US6132753A/en
Priority claimed from US09/260,099 external-priority patent/US6132757A/en
Priority claimed from US09/262,715 external-priority patent/US6187790B1/en
Application filed by RT ALAMO VENTURES Inc, RT ALAMO VENTURES Inc filed Critical RT ALAMO VENTURES Inc
Publication of EP1079764A1 publication Critical patent/EP1079764A1/fr
Publication of EP1079764A4 publication Critical patent/EP1079764A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP99920266A 1998-05-01 1999-04-30 Traitement des troubles de la sexualite chez certains groupes de patients Withdrawn EP1079764A4 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US262715 1981-05-11
US260099 1994-06-15
US09/071,457 US6110489A (en) 1998-05-01 1998-05-01 Use of quinolines and quinolones to treat male erectile dysfunction
US71457 1998-05-01
US166703 1998-10-05
US09/166,703 US6194433B1 (en) 1998-10-05 1998-10-05 Sexual dysfunction in females
US175395 1998-10-19
US09/175,395 US6132753A (en) 1998-05-01 1998-10-19 Treatment of sexual dysfunction in certain patient groups
US09/260,099 US6132757A (en) 1998-05-01 1999-03-02 Treatment of sexual dysfunction in certain patient groups
US09/262,715 US6187790B1 (en) 1999-03-04 1999-03-04 Use of cilostazol for treatment of sexual dysfunction
PCT/US1999/009610 WO1999056666A1 (fr) 1998-05-01 1999-04-30 Traitement des troubles de la sexualite chez certains groupes de patients

Publications (2)

Publication Number Publication Date
EP1079764A1 EP1079764A1 (fr) 2001-03-07
EP1079764A4 true EP1079764A4 (fr) 2001-09-12

Family

ID=27535884

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99920266A Withdrawn EP1079764A4 (fr) 1998-05-01 1999-04-30 Traitement des troubles de la sexualite chez certains groupes de patients

Country Status (7)

Country Link
EP (1) EP1079764A4 (fr)
JP (1) JP2002537231A (fr)
AU (1) AU3780699A (fr)
BR (1) BR9908716A (fr)
CA (1) CA2319542C (fr)
MX (1) MXPA00010254A (fr)
WO (1) WO1999056666A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6548490B1 (en) * 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6541487B1 (en) * 1998-05-01 2003-04-01 R.T. Alamo Ventures I, Llc PDE III inhibitors for treating sexual dysfunction
CA2435876A1 (fr) * 2001-01-26 2002-08-01 R.T. Alamo Ventures I, Llc Traitement de troubles sexuels et de maladie cardio-vasculaire avec des enantiomeres quinolinone
US7041677B2 (en) 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
US6727262B2 (en) 2002-03-01 2004-04-27 R.T. Alamo Ventures I, Llc Dichlorinated heterocyclic compounds and methods of synthesis
US6767914B2 (en) 2002-03-01 2004-07-27 R.T. Alamo Ventures I, Llc Fluorinated heterocyclic compounds and methods of synthesis
US6730790B2 (en) 2002-03-01 2004-05-04 R.T. Alamo Ventures I. Llc Chlorinated heterocyclic compounds and methods of synthesis
GB0208704D0 (en) * 2002-04-16 2002-05-29 Futura Medical Dev Ltd Condom
TWI323660B (en) * 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5270323A (en) * 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
WO1994002144A1 (fr) * 1992-07-21 1994-02-03 The Boots Company Plc Utilisation de 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone dans le traitement de l'angine de poitrine
WO1994028902A1 (fr) * 1993-06-09 1994-12-22 Pfizer Limited Pyrazolopyrimidinones utilisees pour traiter l'impuissance
WO2000007595A1 (fr) * 1998-08-03 2000-02-17 Basf Corporation Utilisation de pyridinones pour traiter les dysfonctionnements sexuels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5270323A (en) * 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
WO1994002144A1 (fr) * 1992-07-21 1994-02-03 The Boots Company Plc Utilisation de 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone dans le traitement de l'angine de poitrine
WO1994028902A1 (fr) * 1993-06-09 1994-12-22 Pfizer Limited Pyrazolopyrimidinones utilisees pour traiter l'impuissance
WO2000007595A1 (fr) * 1998-08-03 2000-02-17 Basf Corporation Utilisation de pyridinones pour traiter les dysfonctionnements sexuels

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
IKEZONO ET AL: "General pharmacological properties of the new vasodilator flosequinan", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH,DE,EDITIO CANTOR. AULENDORF, vol. 42II, no. 10, 1992, pages 1200 - 1211, XP002125660, ISSN: 0004-4172 *
See also references of WO9956666A1 *

Also Published As

Publication number Publication date
WO1999056666A8 (fr) 2000-08-10
BR9908716A (pt) 2000-11-21
EP1079764A1 (fr) 2001-03-07
JP2002537231A (ja) 2002-11-05
WO1999056666A1 (fr) 1999-11-11
CA2319542C (fr) 2005-07-12
CA2319542A1 (fr) 1999-11-11
AU3780699A (en) 1999-11-23
MXPA00010254A (es) 2002-08-06

Similar Documents

Publication Publication Date Title
EP1143987A4 (fr) Composition naturelle et methode destinees au traitement de dysfonctions sexuelles
IL137569A0 (en) Treatment of female sexual dysfunction
EP1027057A4 (fr) Traitement du dysfonctionnement sexuel chez la femme
GB9608408D0 (en) Treatment of erectile dysfunction
HUP0401023A3 (en) Use of flibanserin in the treatment of sexual disorders
HK1015280A1 (en) Use of epinastine in the treatment of pain
HRP980222B1 (en) Pyrazolopyrimidinones for the treatment of sexual disfunction
FI972205A0 (fi) cGmp-PDE:n estäjiä erektiohäiriön hoidossa
GB9824436D0 (en) Methods of treatment
SI1716853T1 (sl) Zdravljenje rakov äśloveĺ kega telesa z uporabo et743
EP1079764A4 (fr) Traitement des troubles de la sexualite chez certains groupes de patients
HK1037517A1 (en) Use of apomorphine in the treatment of premature ejaculation
AU4676099A (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
AU5509099A (en) Pyridinones for the treatment of sexual dysfunction
PL362980A1 (en) Treatment of sexual dysfunction
IL129460A0 (en) Use of lofexidine in the treatment of behavioral disorders
AU2002300509A1 (en) The Treatment of Sexual Dysfunction in Certain Patient Groups
HUP0300043A3 (en) Method and composition for the treatment of pain
GB9904252D0 (en) Composition for the treatment of pain
GB0020261D0 (en) Therapeutic treatment
SI1047428T1 (sl) Uporaba morfolinola za zdravljenje seksualne disfunkcije
GB9603657D0 (en) Improvements in the treatment of vaginal infections
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
GB9827393D0 (en) Treatment of erectile dysfunction in diabetes patients
SI0861081T1 (en) Use of epinastine in the treatment of pain

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000801

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010726

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61F 2/02 A, 7A 61F 13/02 B, 7A 61K 9/20 B, 7A 61K 9/48 B, 7A 61K 31/47 B, 7A 61P 15/10 B

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: R.T. ALAMO VENTURES I, LLC

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061010